In vivo characterization of renal auto-antigens involved in human auto-immune diseases: The case of membranous glomerulonephritis

Corrado Murtas, Maurizio Bruschi, Maria Luisa Carnevali, Andrea Petretto, Emilia Corradini, Marco Prunotto, Giovanni Candiano, Maria Ludovica Degl'Innocenti, Gian Marco Ghiggeri, Landino Allegri

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Renal auto-immune diseases represent a major source of morbidity in humans. For many years the knowledge on mechanisms of auto-immunity involving the kidney has been uniquely based on animal models. However, these findings often could not be readily translated to humans owing to notably difference in antigen expression by human podocytes. One example is Heymann nephritis (HN), the experimental model of human membranous glomerulonephritis (MGN), which is obtained in rats by injecting antibodies against megalin, a protein that is not present in human glomeruli. Human studies could not be done in the past since sequencing required too much material exceeding what obtainable from tissue biopsies in vivo. Research is now on the way to identify auto-antigens and isolate specific auto-antibodies in humans. New technology developments based on tissue microdissection and proteomical analysis have facilitated the recent discoveries, allowing direct analysis of human tissue in vivo. Major advances on the pathogenesis of MGN, the prototype for the formation and glomerular deposition of auto-antibodies, are now in progress. Two independent groups have, in fact, demonstrated the existence of specific IgG4 against phospholipase A2 receptor, aldose reductase and Mn-superoxide dismutase in glomerular eluates and in plasma of a prominent part of patients with MGN, suggesting a major role of these proteins as auto-antigens in human MGN. This review will focalize these aspects outlining the contribution of proteomics in most recent developments.

Original languageEnglish
Pages (from-to)90-97
Number of pages8
JournalProteomics - Clinical Applications
Volume5
Issue number1-2
DOIs
Publication statusPublished - Feb 2011

Fingerprint

Membranous Glomerulonephritis
Immune System Diseases
Tissue
Kidney
Antigens
Phospholipase A2 Receptors
Antibodies
Microdissection
Low Density Lipoprotein Receptor-Related Protein-2
Aldehyde Reductase
Biopsy
Superoxide Dismutase
Rats
Animals
Proteins
Immunoglobulin G
Plasmas
Podocytes
Proteomics
Immunity

Keywords

  • Auto-antigens
  • Auto-immune diseases
  • Membranous Glomenalonephritis

ASJC Scopus subject areas

  • Clinical Biochemistry

Cite this

In vivo characterization of renal auto-antigens involved in human auto-immune diseases : The case of membranous glomerulonephritis. / Murtas, Corrado; Bruschi, Maurizio; Carnevali, Maria Luisa; Petretto, Andrea; Corradini, Emilia; Prunotto, Marco; Candiano, Giovanni; Degl'Innocenti, Maria Ludovica; Ghiggeri, Gian Marco; Allegri, Landino.

In: Proteomics - Clinical Applications, Vol. 5, No. 1-2, 02.2011, p. 90-97.

Research output: Contribution to journalArticle

@article{cd1ba44e9ca642139a07007bb13805bd,
title = "In vivo characterization of renal auto-antigens involved in human auto-immune diseases: The case of membranous glomerulonephritis",
abstract = "Renal auto-immune diseases represent a major source of morbidity in humans. For many years the knowledge on mechanisms of auto-immunity involving the kidney has been uniquely based on animal models. However, these findings often could not be readily translated to humans owing to notably difference in antigen expression by human podocytes. One example is Heymann nephritis (HN), the experimental model of human membranous glomerulonephritis (MGN), which is obtained in rats by injecting antibodies against megalin, a protein that is not present in human glomeruli. Human studies could not be done in the past since sequencing required too much material exceeding what obtainable from tissue biopsies in vivo. Research is now on the way to identify auto-antigens and isolate specific auto-antibodies in humans. New technology developments based on tissue microdissection and proteomical analysis have facilitated the recent discoveries, allowing direct analysis of human tissue in vivo. Major advances on the pathogenesis of MGN, the prototype for the formation and glomerular deposition of auto-antibodies, are now in progress. Two independent groups have, in fact, demonstrated the existence of specific IgG4 against phospholipase A2 receptor, aldose reductase and Mn-superoxide dismutase in glomerular eluates and in plasma of a prominent part of patients with MGN, suggesting a major role of these proteins as auto-antigens in human MGN. This review will focalize these aspects outlining the contribution of proteomics in most recent developments.",
keywords = "Auto-antigens, Auto-immune diseases, Membranous Glomenalonephritis",
author = "Corrado Murtas and Maurizio Bruschi and Carnevali, {Maria Luisa} and Andrea Petretto and Emilia Corradini and Marco Prunotto and Giovanni Candiano and Degl'Innocenti, {Maria Ludovica} and Ghiggeri, {Gian Marco} and Landino Allegri",
year = "2011",
month = "2",
doi = "10.1002/prca.201000079",
language = "English",
volume = "5",
pages = "90--97",
journal = "Proteomics - Clinical Applications",
issn = "1862-8346",
publisher = "Wiley-VCH Verlag",
number = "1-2",

}

TY - JOUR

T1 - In vivo characterization of renal auto-antigens involved in human auto-immune diseases

T2 - The case of membranous glomerulonephritis

AU - Murtas, Corrado

AU - Bruschi, Maurizio

AU - Carnevali, Maria Luisa

AU - Petretto, Andrea

AU - Corradini, Emilia

AU - Prunotto, Marco

AU - Candiano, Giovanni

AU - Degl'Innocenti, Maria Ludovica

AU - Ghiggeri, Gian Marco

AU - Allegri, Landino

PY - 2011/2

Y1 - 2011/2

N2 - Renal auto-immune diseases represent a major source of morbidity in humans. For many years the knowledge on mechanisms of auto-immunity involving the kidney has been uniquely based on animal models. However, these findings often could not be readily translated to humans owing to notably difference in antigen expression by human podocytes. One example is Heymann nephritis (HN), the experimental model of human membranous glomerulonephritis (MGN), which is obtained in rats by injecting antibodies against megalin, a protein that is not present in human glomeruli. Human studies could not be done in the past since sequencing required too much material exceeding what obtainable from tissue biopsies in vivo. Research is now on the way to identify auto-antigens and isolate specific auto-antibodies in humans. New technology developments based on tissue microdissection and proteomical analysis have facilitated the recent discoveries, allowing direct analysis of human tissue in vivo. Major advances on the pathogenesis of MGN, the prototype for the formation and glomerular deposition of auto-antibodies, are now in progress. Two independent groups have, in fact, demonstrated the existence of specific IgG4 against phospholipase A2 receptor, aldose reductase and Mn-superoxide dismutase in glomerular eluates and in plasma of a prominent part of patients with MGN, suggesting a major role of these proteins as auto-antigens in human MGN. This review will focalize these aspects outlining the contribution of proteomics in most recent developments.

AB - Renal auto-immune diseases represent a major source of morbidity in humans. For many years the knowledge on mechanisms of auto-immunity involving the kidney has been uniquely based on animal models. However, these findings often could not be readily translated to humans owing to notably difference in antigen expression by human podocytes. One example is Heymann nephritis (HN), the experimental model of human membranous glomerulonephritis (MGN), which is obtained in rats by injecting antibodies against megalin, a protein that is not present in human glomeruli. Human studies could not be done in the past since sequencing required too much material exceeding what obtainable from tissue biopsies in vivo. Research is now on the way to identify auto-antigens and isolate specific auto-antibodies in humans. New technology developments based on tissue microdissection and proteomical analysis have facilitated the recent discoveries, allowing direct analysis of human tissue in vivo. Major advances on the pathogenesis of MGN, the prototype for the formation and glomerular deposition of auto-antibodies, are now in progress. Two independent groups have, in fact, demonstrated the existence of specific IgG4 against phospholipase A2 receptor, aldose reductase and Mn-superoxide dismutase in glomerular eluates and in plasma of a prominent part of patients with MGN, suggesting a major role of these proteins as auto-antigens in human MGN. This review will focalize these aspects outlining the contribution of proteomics in most recent developments.

KW - Auto-antigens

KW - Auto-immune diseases

KW - Membranous Glomenalonephritis

UR - http://www.scopus.com/inward/record.url?scp=79251541477&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79251541477&partnerID=8YFLogxK

U2 - 10.1002/prca.201000079

DO - 10.1002/prca.201000079

M3 - Article

C2 - 21246743

AN - SCOPUS:79251541477

VL - 5

SP - 90

EP - 97

JO - Proteomics - Clinical Applications

JF - Proteomics - Clinical Applications

SN - 1862-8346

IS - 1-2

ER -